Revised SPC: Kalydeco (ivacaftor) 150 mg Film-coated Tablets

Now licensed for use in combination with ivacaftor 75mg, tezacaftor 50mg, & elexacaftor 100mg for treatment of adults and adolescents aged ≥12 years who are homozygous for F508del mutation in CFTR gene or heterozygous for F508del in CFTR gene with minimal function mutation.


electronic Medicines compendium